#1AN INTRODUCTION TO BEAUTYHEALTH SKIN Nasdaq Listed June 2022 ydrafacial BEAUTYHEALTH#2DISCLAIMER This Presentation contains certain forward-looking statements. These statements may relate to, but are not limited to, expectations of future operating results or financial performance of The Beauty Health Company (the "Company"), the calculation of certain key financial and operating metrics, capital expenditures, the introduction of new products, expansion into new markets, projections of market opportunity, and the ability to execute certain strategic initiatives. Some of the forward-looking statements can be identified by the use of forward-looking words such as "anticipate," "expect," "suggests," "plan," "believe," "intend," "estimates," "targets," "projects," "should," "could," "would," "may," "will," "forecast" and other similar expressions. These are intended to identify forward-looking statements. All forward-looking statements are based upon management estimates and forecasts and reflect the views, assumptions, expectations, and opinions of the Company as of the date of this Presentation, and may include, without limitation, changes in general economic conditions as a result of COVID-19, all of which are subject to change. Any such estimates, assumptions, expectations, forecasts, views or opinions set forth in this Presentation constitute the Company's judgments and should be regarded as indicative, preliminary and for illustrative purposes only. The forward-looking statements and projections contained in this Presentation are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause the Company's actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial condition. Although such forward-looking statements have been made in good faith and are based on assumptions we believe to be reasonable, there is no assurance that the expected results will be achieved. Many factors could adversely affect our business and financial performance. We discussed a number of material risks in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 1, 2022 and other filings with the Securities and Exchange Commission. Those risks continue to be relevant to our performance and financial condition. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We expressly disclaim any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise. Description of Non-GAAP Financial Measures In addition to results determined in accordance with accounting principles generally accepted in the United States of America (GAAP), management utilizes certain non-GAAP financial measures such as adjusted gross margin, adjusted EBITDA, adjusted EBITDA margin, and Adjusted Net Income (Loss) for purposes of evaluating ongoing operations and for internal planning and forecasting purposes. We believe these non-GAAP financial measures, when reviewed collectively with our GAAP financial information, provide useful supplemental information to investors in assessing our operating performance. These non-GAAP financial measures should not be considered as an alternative to GAAP financial information or as an indication of operating performance or any other measure of performance derived in accordance with GAAP, and may not provide information that is directly comparable to that provided by other companies in its industry, as these other companies may calculate non-GAAP financial measures differently, particularly related to non-recurring, unusual items. Management uses adjusted gross margin to measure profitability and the ability to scale and leverage the costs of Delivery Systems and Consumables. The continued growth of Delivery Systems is expected to improve adjusted gross margin, as additional Delivery Systems sold will increase our recurring Consumables net sales, which has higher margins. Management believes adjusted gross profit and adjusted gross margin are useful measures to the Company and its investors to assist in evaluating operating performance because they provide consistency and direct comparability with past financial performance and between fiscal periods, as the metrics eliminate the effects of amortization and depreciation, which are non-cash expenses that may fluctuate for reasons unrelated to overall continuing operating performance. Adjusted gross margin has been and will continue to be impacted by a variety of factors, including the product mix, geographic mix, direct vs. indirect mix, the average selling price on Delivery Systems, and new product launches. Management expects adjusted gross margin to fluctuate over time depending on the factors described above. Management uses adjusted EBITDA and adjusted EBITDA margin to facilitate internal comparisons of historical operating performance on a more consistent basis and uses these measures for business planning purposes. Management also believes this information will be useful for investors to facilitate comparisons of operating performance and better identify trends in the business. Management expects adjusted EBITDA margin to increase over the long-term, as the Company continues to scale and achieve greater operating leverage. The Company calculates adjusted EBITDA as net income (loss) adjusted to exclude: change in fair value of public and private placement warrants, change in fair value of earn-out shares liability, other expense, net; interest expense; income tax benefit (expense); depreciation and amortization expense; stock-based compensation expense; foreign currency (gain) loss; management fees incurred from historical private equity owners; one-time or non-recurring items such as transaction costs (including transactions costs with respect to the Business Combination); and restructuring costs (including those associated with COVID-19). Management uses Adjusted Net Income (Loss) to facilitate internal comparisons of historical operating performance on a more consistent basis and uses these measures for business planning purposes. The Company calculates Adjusted Net Income (Loss) as net income (loss) adjusted to exclude: change in fair value of Public and Private Placement Warrants, change in fair value of earn-out shares liability, other expense (income), net; amortization expense; stock-based compensation expense; management fees incurred from our historical private equity owners; one-time or non-recurring items such as transaction costs (including transactions costs with respect to the Business Combination); restructuring costs (including those associated with COVID-19) and the aggregate adjustment for income taxes for the tax effect of the adjustments described above. 2 BEAUTYHEALTH™#3ANDREW STANLEICK President and Chief Executive Officer LIYUAN WOO Chief Financial Officer ● Joined Beauty Health in February 2022 • Former EVP Americas, Coty; CEO, Kylie Jenner Beauty Advised Kim Kardashian on her KKW Beauty business President, COACH Europe and COACH Asia • Unilever and L'Oréal marketing and GM roles (Europe, Russia, and APAC) ● ● ● ABOUT THE PRESENTERS Joined BeautyHealth in September 2020 • Former COO and CFO of The VOID, a virtual reality entertainment company ● COTY KYLIE COSMETICS KKW BEAUTY SINCE 1904 Served as CFO for SharkNinja, Gymboree, and bebe Deloitte M&A and Financial Advisory Services B ● bebe Shark NINJA COACH L'ORÉAL NEW YORK 3 GYMBOREE Unilever Deloitte. BEAUTYHEALTH™#41. AGENDA Introduction to Beauty Health 2. Financial Overview 3. Closing Remarks 4 BEAUTYHEALTH™#51 hydrafacial Beauty 5 INTRODUCTION TO BEAUTYHEALTH ANDREW STANLEICK President and Chief Executive Officer BEAUTYHEALTH#6INTRODUCTION TO BEAUTYHEALTH Proven category creator and community Digital platform builder with global runway Growth-minded with demonstrated profitability Essential, not discretionary, purveyor of confidence On an Adjusted EBITDA basis, which is a non-GAAP measure; please refer to the appendix for a reconciliation to the appropriate GAAP measure 6 BEAUTY IS A FEELING IF YOU KNOW YOU GLOW BEAUTYHEALTH™#7UNIQUELY POSITIONED AT THE CONVERGENCE OF LARGE & HIGH-GROWTH CATEGORIES Favorable industry tailwinds BEAUTY HEALTH I EXPANDING DEMOGRAPHICS NON- INVASIVE Bridging non-invasive beauty and invasive aesthetics Medical Light Basic Micro Micro- Chemical Lasers Injectables Non- Plastic grade therapy facial derma- needling peels surgical face lifts surgery skincare brasion Generations M >30% of customers at beauty retailers are <24 Genders ** Providers predict ~2x growth in male mix of total facial patients INVASIVE Geographies ~70% of global population resides in Asia & Europe AESTHETICS Category Wellness Personal Care & Beauty Skincare Haircare Spa Services Aesthetics Source: Third party research 2019 reflecting pre-COVID conditions; United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019, Online Edition. Rev. 1; McKinsey & Company for 2021 estimated wellness market size and growth; Global Wellness Institute for 2020 estimated personal care & beauty market size and growth; Statista for 2021 estimated market size for skincare and haircare and growth; Grand View Research for 2020 estimated spa market size and growth; Vantage Market Research for 2022 estimated market size and growth '7 WELLNESS ~TAM ($bn) $1,500 955 155 95 48 12 BEAUTY Growth 5-10% 8% 5% 3% 12% 11% BEAUTYHEALTH™#8h hydrafacial hydrafacial BEAUTYHEALTH™ 8 1 рейтргарб | S]467 NA BEAUTYHEALTH™#9We are for everyone CREATING THE CATEGORY hydrafacial BEAUTYHEALTH We are more than a facial We are an & company We are a proven category-creator ¹ Includes 28 issued US patents and 21 pending US and PCT applications I ■ I I 1 Instant gratification. Non-invasive. No downtime. No pain. Effective for all ages, genders, skin tones, and skin types Patented Vortex Fusion painlessly cleanses, extracts, and hydrates Applicable to more than just the face Face Lips Scalp Back Décolleté Booty Works with other procedures and partners with leading brands Omnichannel distribution. First microdermabrasion device to market Nearly 50 patents on our technology 9 ydrafacial ydffcl hydra BEAUTYHEALTH#101 2 Cleanse Extract Gentle exfoliation and relaxing resurfacing to Remove debris from pores with painless uncover a new layer of skin Suction Base tip / $200 Average cost to consumer¹ Monthly Recommended frequency Upsells Available upgrades Treatment options Platinum Deluxe THE HYDRAFACIAL EXPERIENCE 3 STEPS. 30 MINUTES. BEST SKIN OF YOUR LIFE! Signature 1 Third party research 2019 reflecting pre-COVID conditions; 2 Excludes J Lo Beauty Booster launching Fall 2022 Boosters Extraction tip Personalized serums for specific concerns More than a dozen available (partnered with eight leading skincare brands)2 10 HEA 3 Hydrate Saturate surface with antioxidants and peptides to create instantly gratifying glow Vortex Fusion tip HydraFacial Keravive ■ Extract impurities from scalp and follicles Saturate scalp with peptide complex clinically shown to lead to healthier and fuller-looking hair HYDRAFACIAL KERAVIVE ! hydrafacial keravive. COMPLETE KIT COFFRET COMPLET (263991 HYDRAFACIAL KERAVIVE PapSop hydrafacial keravive. PEPTIDE COMPLEX SPRA FOR SCALP REILTE 2:12/0 BEAUTYHEALTH#11Key Opinion Leader AGILE MARKETING TO BUILD COMMUNITY AND BRAND AWARENESS 245K Followers 2M #hydrafacial posts Influence from all channels 12, KOL¹ AESTHETICIANS INFLUENCERS CELEBRITIES afacial GET THE estic 11 op 315M #hydrafacial views THE BEST SKIN R LIFE hydrafacial SEUTUCAN IT'S GLOW TIME CAFE STOR hydrafac hydrafacial BEAUTYHEALTH hydrafacial ******* FOND Cotection 400 drafacial BEAUTYHEALTH#12D F hydrafacial URAFAC HFX ■ BECOMING THE LARGEST DEPLOYER OF AESTHETICIANS WORLDWIDE HEX THE HYDRAFACIAL EXPERIENCE Network of global training and education centers hosting workshops and events for our community hydrafacial CONNECT First-of-its-kind beauty health industry certification for providers Impact ✓ ~5K providers trained in 2021 ✓ Builds trust and affinity ✓ Accelerated growth in consumables purchases and system sales by trainees 12 BEAUTYHEALTH™#13WE ARE AN & COMPANY ▪ Omnichannel strategy - average consumer visits 3.2 locations¹ ▪ Can be standalone or combined with other procedures 95% of HydraFacial consumers use other beauty treatments¹ ▪ Co-branded boosters for personalized experiences Booster partnerships Potential non-medical channels Potential medical channels U HYDRAFACIAL ROZATROL BOOSTER SERUM SERUM REVITALISANT ROZATROL HYDRAFACIAL/30 O us FOR PROFESSIONAL USE ONLY, NOT FOR RESALE SINGLE USE DO NOT REFEL HYDRAFACIAL BRIGHTALIVE BOOSTER SERUM SERUM SUBLIMATEUR HYDRAFADAL BRIGHTALIVE/N03011 Cz. U.S. FOR PROFESSIONAL USE ONLY. NOT FOR RESALE SINGLE USE DO NOT REPELL 0:38/9 Powered by SENTE's potented HSA CHeparan Sulfate Analog) 9mL/0.30 FL OZ SENTÉ HydraFacial Dermal Repair Booster NASSIFMD HYDRAGLUCAN Delivered by HydraFacial Ner9 m/0.30 R. oz. U.S. SE CHEX, NOT FOR REAL Murad, VITA-C BOOSTER Delivered by HydraFacial™ Not 9 ml / 0.30 oz U.S. FOR PROFESSIONAL USE ONLY, NOT FOR RESALE SINGLE USE DO NOT REFILL DIRECTIONS AND INGREDIENTS: Los de Murad, RETINOL BOOSTER Delivered by Hydrafacial Netml/0.30 for US DIRECTIONS AND INGECOM FOR RESALE SINGLE USE DO NOT REFILL HydroPeptive Delivered by HydraFacial 9 ml / Net 0.30 fi oz U.S. POWER SERUM FOR PROFESSIONAL USE ONLY, NOT FOR RESALE. Delivered by HydraFacial Net9m/0.30 oz U.S. NECK AND DÉCOLLETÉ BOOSTER ONLY, NOT FOR REATE VITAL DEFENSE BOOSTER PROTEC PLUS maar NOT FOR RESALE SKIN ENERGIZING BOOSTER CHRONO-PEPTIDE 9 ml / Net 0.30 Fl. Oz. U.S. Gyms / Studios Experiential Retail Cruises Delivered by HydraFacial TRIHEX-PRO Beauty Retail Medical Spas Plastic and Aesthetic Surgeons Dermatologists SEPICUTIS. 6 50 QA Travel Retail Salons Non-medical Spas Hotels Resorts 1 Third party research 2019 reflecting pre-COVID conditions BEAUTYHEALTH™ 13#14Office & Assembly Facility, Long Beach, CA F LOVED AROUND THE WORLD... AND NEAR YOU STARTS WAL FACE LIFE FACE FIRS Ⓒliydrafacial London Experience Center Glow -Getter Shanghai Experience Center Though LA MA New York Experience Center THE HYDRAFACIAL BRAND VISION Tokyo Experience Center なぜ歯科クリニックで導入しようと思ったのか? ○ 私自身が美容皮膚科で受けてみて気に入っていた 矯正患者さんに「もう一歩先のキレイ」を提供したい ○矯正治療やホワイトニングをご希望される方は ハイドラフェイシャルにもご興味があるに違いない! ○歯のケアとスキンケアが一緒にできることは 他院との差別化に繋がるのでは? GLOWvolution Mobile Installation BEALTYHEALTH 14 1 #GLOWvolution 17 11 Global Experience Centers 15 Direct Markets ++ 90+ Countries BEAUTYHEALTH™#15drafacial hydrafacial BEAUTY IS A FEELING 20 COMPETITIVE STRENGTHS Patented Technology & Compelling Clinicals Asset-Light High Margin & Company 15 ∞ Engaged Community пелеле Nascent and Large TAM Agile Marketing لكم BEAUTYHEALTH™#16SEEKING TO SUPERCHARGE THE PLATFORM WITH ACQUISITIONS Acquisition criteria MEDICAL AESTHETICS TRADITIONAL BEAUTY WELLNESS 1 Differentiated product or service / high Net Promoter Score 2) Complementary to our existing platform and community, leveraging the trusted aesthetician 3) Financially attractive profile via compelling revenue growth, recurring revenue characteristics, and / or profitability 16 BEAUTYHEALTH™#17CALM HYDRATE FIRM 17 FINANCIAL OVERVIEW LIYUAN WOO Chief Financial Officer BEAUTYHEALTH#18Deline HydraFacial Booster Edit Treatment Instructions Replies the whschoolger in the hare with you selechar Po and Une clions of hard res of the face decunding on the booke siedoc Adut how vove depending on the product < n Davice Tip 02 Che hydrafacial Booster Chimilis? Putoc por CLEANSE Treatment Pattern ss and wist Apply to Dark Spots as Nasory Step 1 EXTRACT Stop 2 Step 3 ANTIOX + 11:16 AM Vacuum 16 STOP Ger Consumables THE HYDRAFACIAL ECONOMIC MODEL Consumables re-ordered 3 Tips 1 Delivery System sold HydraFacial performed on consumer 2 18 Delivery Systems Solutions CLEANSE Exfolding So hydrafacial Ellz US/237 ml S 2002 S Ide · plakp. hydrafacial Syndeo (US) EXTRACT" exiving So on détox are A hydrafacial Quarterly KPIs ! HYDRATE™ Hyolmonic Acid & dent Moisturizing So Strychu Khetroce hydrafacial 81 az US/237 ml Elite (ex-US) 1 DEVICE RINSE en Clean yo d hydrafacial Bill or US / 237 BRITENOL Alpha Arbutin & Vitamin C Brightening Solution Perk Boosters — Perk 1 DERMABUILDER™ hydrafacial Allegro Skin Perfecting Protein Solution with M-007 To ReGen GF™ + Co-branded partnerships BEAUTYHEALTH™#19Net Sales ($mm) Delivery System Install Base % Revenue Americas EMEA APAC Excludes 2020 due to the impact of COVID-19 $112.3 49% 51% 2018 79% 15% 6% 10,524 2018 COMPELLING GROWTH PROFILE $166.6 51% 49% 2019 73% 17% 9% 13,872 2019 Systems Consumables 2018-2021 CAGR: 52%¹ 19 $119.1 55% 45% 2020 68% 19% 12% 15,689 2020 $260.1 46% 54% 2021 65% 18% 17% 20,399 2021 $75.4 45% 55% 1Q22 59% 24% 17% 21,719 1Q22 BEAUTYHEALTH™#20Gross margin 63.9% 2019 56.4% 2020 GAAP Gross Margin 69.9% 2021 COMPELLING GROWTH PROFILE (CONT'D) 70.7% 2019 65.5% Non-GAAP measure; please refer to the appendix for a reconciliation to the appropriate GAAP measure 74.0% 2020 Adjusted Gross Margin¹ 2021 20 Net loss ($mm) $1.6 2019 Adjusted Net Income (Loss) ¹ Adjusted EBITDA ($mm)¹ $36.7 22.0% 2019 6.5% $29.2 2020 ($12.1)) % margin $7.7 2020 $375.1 2021 $4.5 $32.7 12.6% 2021 BEAUTYHEALTH™#21Recent highlights Nasdaq listing May 2021 hydrafacial SKIN | Nasdaq Listed I Nasdaq 3 DEMONSTRATED TRACK RECORD OF SUCCESS 4 Distributors acquired 1 Phase I (Americas rollout) implemented; Phase II (global rollout) underway O Global ERP Implemented¹ 0 10 10 0 10: 01001 10 1 0 1001 10 1 10 1 0 0101 0 10 01 0 14 0 100 1 0 10 1 0 21 0 5 $750,000,000 Network optimization Convertible debt raised % 2 00 9 6 3 X + Underway BEAUTYHEALTH#22WELL POSITIONED TO CONTINUE GROWTH MOMENTUM Place systems Expand into new accounts 2nd system sales I fy. Increase utilization Upsell treatments and add-ons Leverage digital connectivity to improve performance Drive brand awareness High ROI and agile marketing initiatives Partner with thought leaders to broaden reach 22 ■ Expand globally Build commercial infrastructure to penetrate vast global opportunity ▪ Increase penetration in still-early US home market I M&A Disciplined approach Acquire complementary brands that benefit HydraFacial Nation BEAUTYHEALTH™#234 ! 23 CLOSING REMARKS ANDREW STANLEICK President and Chief Executive Officer BEAUTYHEALTH#241 ♡ BEAUTYHEALTH™ 5 THE MASTER PLAN Expand footprint and provide connected experiences. 2 Invest in our providers to build trust and loyalty 3 Drive brand awareness and consumer engageme 4 Build global infrastructure Supercharge platform with targeted acquisitions. 24 BEAUTYHEALTH™#25WE ARE A CATEGORY CREATOR... ♡ BEAUTYHEALTH™ DEMONSTRATING EXCITING GROWTH... 25 USING A PROFITABLE & SCALABLE BUSINESS MODEL... IN A MARKET WITH HUGE GLOBAL OPPORTUNITY. BEAUTYHEALTH™#26Grader O Wifi Love Gast LOVED AROUND THE WORLD AND NEAR YOU face life face first 26 ESTIC APPENDIX BEAUTYHEALTH#27Reconciliation of Gross Profit to Adjusted Gross Profit ($mm) Net sales Less: cost of sales Gross profit Gross margin Adjusted to exclude the following: Stock-based compensation expense Depreciation and amortization expense Adjusted gross profit Adjusted gross margin Unaudited (in thousands) Net loss Adjusted to exclude the following: Change in FV of warrant liability Change in FV of earn-out shares liability RECONCILIATION OF NON-GAAP MEASURES Reconciliation of Net loss to Adjusted Net Income (Loss) Amortization expense Stock-based compensation expense Other expense (income) Management fees ¹ Transaction related costs² Other non-recurring and one-time fees³ Aggregate adjustment for income taxes Adjusted Net Income (Loss) Year Ended December 31, 2020 $119.1 ($51.9) $67.2 56.4% 2021 $260.1 ($78.3) $181.8 69.9% 0.4 10.3 $192.5 74.0% Year Ended December 31, 2021 ($375.1) 277.3 47.1 13.3 12.4 4.5 0.2 34.9 4.0 (14.1) $4.5 10.8 $78.0 65.5% 2020 ($29.2) 2019 $166.6 ($60.1) $106.5 63.9% 11.3 $117.8 70.7% Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDA Margin 27 ($mm) Net sales Net income (loss) Adjusted to exclude the following: Change in fair value of warrant liability Change in fair value of earn-out shares liability Depreciation & amortization expense Stock-based compensation expense Interest expense Income tax benefit Foreign currency loss, net Other expense (income) Management fees Transaction related costs² Other non-recurring and one-time fees³ Adjusted EBITDA Adjusted EBITDA margin Year Ended December 31, 2020 $119.1 (29.2) 2021 $260.1 (375.1) 277.3 47.1 17.8 12.4 11.8 (2.2) 0.1 4.5 0.2 34.9 4.0 $32.7 12.6% 14.5 0.4 21.3 (9.3) 0.0 1.5 4.2 4.3 $7.7 6.5% 12.0 0.4 0.0 1.5 4.2 4.3 (5.4) ($12.1) 1 Represents quarterly management fees paid to the former majority shareholder of the Company based on a pre-determined formula. Following the Business Combination, these fees are no longer paid; 2 For the year ended December 31, 2021, such amounts primarily represent direct costs incurred with the Business Combination, including $21.0 million paid to the former owner of HydraFacial, and to prepare HydraFacial to be marketed for sale by HydraFacial's shareholders in previous periods; 3 For year ended December 31, 2021, such costs primarily represent one time retention awards related to the distributor acquisitions and executive recruiting and severance fees. For the year ended December 31, 2020, such costs primarily represent COVID-19 related restructuring cost of $3.2 million, including write-off of expired Consumables, discontinued product lines, human capital, cash management consultant fees, and, to a lesser extent, costs associated with a former warehouse and assembly facility during the transition period. For the year ended December 31, 2019, such costs include approximately $4.0 million related to the move from a former warehouse and assembly facility to a new warehouse and assembly facility, approximately $1.4 million to defend certain patents that were being infringed upon, and personnel costs associated with the restructuring of HydraFacial's salesforce, partially offset by a legal settlement received in favor of HydraFacial. BEAUTYHEALTH 2019 $166.6 (1.6) 13.9 0.1 17.1 (1.3) (0.2) (0.5) 1.8 1.7 5.7 $36.7 22.0%#28♡ BEAUTYHEALTH™